News

Filter

Current filters:

Skelaxin

1 to 9 of 43 results

King swings to loss in 1st qtr on Alpharma costs

12-05-2009

King Pharmaceuticals' first-quarter 2009 revenues inched down 0.7% year-on-year to $429.0 million and…

AlpharmaAltaceAvinzaKing PharmaceuticalsMetaxaloneMorphine SulfateRamipril TabletsRoxanolSkelaxinThrombin Topical Bovine OriginThrombin-JMI

Stock Commentary - New York week to Feb 9, 2009

16-02-2009

NEW YORK: equities started the reporting period to February 9, with a 1.8% bounce after four sessions…

AlpharmaAmylinezetimibeEzetimibe and SimvastatinMetaxaloneSchering PloughSchering-PloughSimvastatinSkelaxinVytorinZetiaZocor

King to reduce its workforce 20%

16-02-2009

The USA's King Pharmaceuticals plans to reduces it workforce by 22% to lose a total of 760 employees.…

AlpharmaKing PharmaceuticalsMetaxaloneSkelaxin

Stock Commentary - New York week to Jan 14, 2008

21-01-2008

NEW YORK: equities suffered a roller-coaster week to January 14, buffeted by ongoing concerns about the…

MetaxaloneSkelaxin

1 to 9 of 43 results

COMPANY SPOTLIGHT

Menarini

Back to top